tirzepatide and drinking alcohol Tirzepatide: Safety Tips for Weight Loss Tirzepatide and Alcohol: Safe Guidelines

Weight loss is the most visible change, with clinical trials demonstrating average reductions that vary by medication: approximately 5-10% with liraglutide (Saxenda), 15-17% with semaglutide 2.4mg (Wegovy) in the STEP trials, and up to 20% with higher doses of tirzepatide in the SURMOUNT programme

Wegovy: Is administered in higher doses, specifically for weight loss

Clinical trials show nausea occurs in roughly 20 to 30 percent of patients at starting doses, and the severity ranges from mild queasiness to more pronounced symptoms that usually resolve within a week

During methylation, methyl groups are usually attached to the DNA, especially to the cytosines that precede the guanines (CpG sites), resulting in 5-methylcytosine (5mC)